AU2015216783A1 - Filarial nematode vaccines, polypeptides, and nucleic acids - Google Patents

Filarial nematode vaccines, polypeptides, and nucleic acids Download PDF

Info

Publication number
AU2015216783A1
AU2015216783A1 AU2015216783A AU2015216783A AU2015216783A1 AU 2015216783 A1 AU2015216783 A1 AU 2015216783A1 AU 2015216783 A AU2015216783 A AU 2015216783A AU 2015216783 A AU2015216783 A AU 2015216783A AU 2015216783 A1 AU2015216783 A1 AU 2015216783A1
Authority
AU
Australia
Prior art keywords
polypeptide
shk
nucleic acid
protein
filarial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015216783A
Other languages
English (en)
Inventor
Stuart Armstrong
Simon BABAYAN
Mark BLAXTER
Ben MAKEPEACE
David Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
University of Edinburgh
Original Assignee
University of Liverpool
University of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool, University of Edinburgh filed Critical University of Liverpool
Publication of AU2015216783A1 publication Critical patent/AU2015216783A1/en
Priority to AU2019222839A priority Critical patent/AU2019222839B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2015216783A 2014-02-11 2015-02-11 Filarial nematode vaccines, polypeptides, and nucleic acids Abandoned AU2015216783A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2019222839A AU2019222839B2 (en) 2014-02-11 2019-08-28 Filarial nematode vaccines, polypeptides, and nucleic acids

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1402352.7A GB201402352D0 (en) 2014-02-11 2014-02-11 Vaccines, polypeptides, and nucleic acids
GB1402352.7 2014-02-11
PCT/GB2015/050380 WO2015121646A1 (en) 2014-02-11 2015-02-11 Filarial nematode vaccines, polypeptides, and nucleic acids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2019222839A Division AU2019222839B2 (en) 2014-02-11 2019-08-28 Filarial nematode vaccines, polypeptides, and nucleic acids

Publications (1)

Publication Number Publication Date
AU2015216783A1 true AU2015216783A1 (en) 2016-09-22

Family

ID=50390804

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2015216783A Abandoned AU2015216783A1 (en) 2014-02-11 2015-02-11 Filarial nematode vaccines, polypeptides, and nucleic acids
AU2019222839A Ceased AU2019222839B2 (en) 2014-02-11 2019-08-28 Filarial nematode vaccines, polypeptides, and nucleic acids

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2019222839A Ceased AU2019222839B2 (en) 2014-02-11 2019-08-28 Filarial nematode vaccines, polypeptides, and nucleic acids

Country Status (7)

Country Link
US (2) US9994624B2 (enExample)
EP (2) EP3693008A1 (enExample)
JP (1) JP2017512066A (enExample)
AU (2) AU2015216783A1 (enExample)
CA (1) CA2939236C (enExample)
GB (1) GB201402352D0 (enExample)
WO (1) WO2015121646A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201402352D0 (en) 2014-02-11 2014-03-26 Univ Liverpool Vaccines, polypeptides, and nucleic acids
WO2017173369A1 (en) 2016-04-01 2017-10-05 New York Blood Center, Inc. Biomakers and immunogenic compositions for filarial parasites
WO2017176950A2 (en) 2016-04-07 2017-10-12 Merial, Inc. Heartworm vaccine, methods and uses thereof
MX2024004078A (es) * 2021-10-04 2024-04-18 Agresearch Ltd Vacuna contra nematodos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265198B1 (en) 1994-05-26 2001-07-24 Heska Corporation Parasite astacin metalloendopeptidase proteins
MY160430A (en) 2008-12-12 2017-03-15 Univ Sains Malaysia Recombinant antigen for detection of toxocariasis
US20130236490A1 (en) 2010-11-15 2013-09-12 The Board Of Trustees Of The University Of Illinois Multivalent Vaccine for Filariasis
GB201402352D0 (en) 2014-02-11 2014-03-26 Univ Liverpool Vaccines, polypeptides, and nucleic acids

Also Published As

Publication number Publication date
US9994624B2 (en) 2018-06-12
US10919944B2 (en) 2021-02-16
AU2019222839A1 (en) 2019-09-19
US20170051024A1 (en) 2017-02-23
CA2939236A1 (en) 2015-08-20
WO2015121646A1 (en) 2015-08-20
EP3693008A1 (en) 2020-08-12
EP3104876A1 (en) 2016-12-21
GB201402352D0 (en) 2014-03-26
JP2017512066A (ja) 2017-05-18
AU2019222839B2 (en) 2021-07-08
US20180355002A1 (en) 2018-12-13
CA2939236C (en) 2023-02-21

Similar Documents

Publication Publication Date Title
McNeilly et al. Immune modulation by helminth parasites of ruminants: implications for vaccine development and host immune competence
AU2019222839B2 (en) Filarial nematode vaccines, polypeptides, and nucleic acids
Hewitson et al. Secretion of protective antigens by tissue-stage nematode larvae revealed by proteomic analysis and vaccination-induced sterile immunity
Zhan et al. Molecular characterisation of the Ancylostoma-secreted protein family from the adult stage of Ancylostoma caninum
Li et al. Trichinella spiralis: low vaccine potential of glutathione S-transferase against infections in mice
Ramachandran et al. The larval specific lymphatic filarial ALT‐2: induction of protection using protein or DNA vaccination
Bartley et al. Assessment of cathepsin D and L-like proteinases of poultry red mite, Dermanyssus gallinae (De Geer), as potential vaccine antigens
Hagel et al. Ascaris lumbricoides: an overview of therapeutic targets
Shaw et al. Identification and characterisation of an aspartyl protease inhibitor homologue as a major allergen of Trichostrongylus colubriformis
Singh et al. Cofactor independent phosphoglycerate mutase of Brugia malayi induces a mixed Th1/Th2 type immune response and inhibits larval development in the host
Noon et al. A highly expressed intestinal cysteine protease of Ancylostoma ceylanicum protects vaccinated hamsters from hookworm infection
Dicker et al. Proteomic analysis of Mecistocirrus digitatus and Haemonchus contortus intestinal protein extracts and subsequent efficacy testing in a vaccine trial
Arumugam et al. Vaccination with a genetically modified Brugia malayi cysteine protease inhibitor-2 reduces adult parasite numbers and affects the fertility of female worms following a subcutaneous challenge of Mongolian gerbils (Meriones unguiculatus) with B. malayi infective larvae
Sahoo et al. Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection
Zhan et al. Advancing a human onchocerciasis vaccine from antigen discovery to efficacy studies against natural infection of cattle with Onchocerca ochengi
Boag et al. Characterisation of humoral immune responses in dogs vaccinated with irradiated Ancylostoma caninum
Geldhof et al. Characterisation of the two most abundant genes in the Haemonchus contortus expressed sequence tag dataset
Chen et al. Expression and immune response analysis of Schistosoma japonicum VAL-1, a homologue of vespid venom allergens
Tsubokawa et al. Venestatin, a Ca++-binding protein from the parasitic nematode Strongyloides venezuelensis, is involved in the larval migration process
Nisbet et al. Molecular characterization, expression and localization of tropomyosin and paramyosin immunodominant allergens from sheep scab mites (Psoroptes ovis)
Don et al. Saposin-like proteins from the intestine of the blood-feeding hookworm, Ancylostoma caninum
Visser et al. Gender-enriched transcription of activation associated secreted proteins in Ostertagia ostertagi
EP3271023A1 (en) Immunogenic compositions and vaccines for preventing or treating filarial disease
AU2019336212B2 (en) Compositions and methods for preventing and/or treating filarial disease
Arnoldi Oltre la puntura della zanzara tigre: i molteplici ruoli della saliva di Aedes albopictus

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted